Orthofix Medical Inc. Future Amortization Expense, after Year Five (Deprecated 2012-01-31)
Orthofix Medical Inc. (OFIX) reported Future Amortization Expense, after Year Five (Deprecated 2012-01-31) of $1.10 million for the 12-month period ending 2011-12-31, per its 10-K filed 2012-02-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseAfterYearFive · last filed 2012-02-29
- Orthofix Medical Inc. future amortization expense, after year five (deprecated 2012-01-31) for fiscal 2011 was $1.10M.
| Period end | Future Amortization Expense, after Year Five (Deprecated 2012-01-31) 12 month |
|---|---|
| 2011-12-31 | $1.10M 10-K · filed 2012-02-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |